Quality of life after cancer—How the extent of impairment is influenced by patient characteristics

BMC Cancer

Table 4 Shows mean scale values from the study population compared to the healthy population sample [16] in different age groups

Score	Age ^a	M ± SD study population	M healthy population ^b	Difference
gQoL	≤39	53.78 ± 20.34	81.70	27.92
	40–59	47.25 ± 22.27	72.85	25.60
	≥60	51.33 ± 21.67	63.55	12.22
PF	≤39	71.68 ± 20.80	98.10	26.42
	40–59	67.52 ± 21.20	94.30	26.78
	≥60	64,50 ± 20,49	82,43	17.93
EF	≤39	54.37 ± 25.71	84.80	30.43
	40–59	46.87 ± 28.85	80.15	33.28
	≥60	55.02 ± 28.02	81.00	25.98
CF	≤39	68.72 ± 26.98	96.95	28.23
	40–59	62.42 ± 30.54	94.30	31.88
	≥60	69.72 ± 27.44	86.30	16.58
SF	≤39	52.84 ± 30.13	97.30	44.46
	40–59	56.19 ± 32.75	92.85	36.66
	≥60	62.75 ± 30.83	86.00	23.25
RF	≤39	54.97 ± 29.83	96.70	41.73
	40-59	50.75 ± 31.15	90.80	40.05
	≥60	51.88 ± 30.76	81.40	29.52
F	≤39	51.13 ± 27.23	7.60	43.53
	40–59	57.12 ± 27.67	12.15	44.97
	≥60	56.51 ± 20.34	23.20	33.31

Abbreviations: gQoL global quality of life, PF physical functioning, EF emotional functioning, CF cognitive functioning, SF social functioning, RF role functioning, F fatigue
^a in years
^b Schwarz & Hinz, 2001; no SD values given

ISSN: 1471-2407